BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 34549835)

  • 1. Adenoid ameloblastoma with dentinoid is molecularly different from ameloblastomas and adenomatoid odontogenic tumors.
    Coura BP; Dos Santos JN; Fonseca FP; Bernardes VF; de Aquino SN; Jorge Júnior J; Vargas PA; Romañach MJ; de Andrade BAB; Gomez RS; Gomes CC
    J Oral Pathol Med; 2021 Nov; 50(10):1067-1071. PubMed ID: 34549835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenoid ameloblastoma harbors beta-catenin mutations.
    Bastos VC; Coura BP; Guimarães LM; Fernandes BG; Chan AC; Vargas PA; Bastos-Rodrigues L; De Marco LA; Hellstein J; Thavaraj S; Wright JM; Odell EW; Gomez RS; Gomes CC
    Mod Pathol; 2022 Nov; 35(11):1562-1569. PubMed ID: 35840721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenoid Ameloblastoma with BRAF p.V600E Mutation Revealing Ameloblastomatous Origin: A First Case Report.
    Noda Y; Sawada S; Sakagami T; Kojima Y; Higasa K; Tsuta K
    Head Neck Pathol; 2023 Sep; 17(3):788-792. PubMed ID: 37093491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BRAF V600E and previously unidentified KRAS G12C mutations in odontogenic tumors may affect MAPK activation differently depending on tumor type.
    Oh KY; Kim JH; Cho SD; Yoon HJ; Lee JI; Hong SD
    Genes Chromosomes Cancer; 2022 Aug; 61(8):481-490. PubMed ID: 35353428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing pathogenic mutations in dental follicles as an attempt to identify early events in odontogenic tumours tumourigenesis.
    Coura BP; de Resende TAC; de Menezes VCB; Bernardes VF; de Sousa SF; Diniz MG; Gomez RS; Gomes CC
    Arch Oral Biol; 2020 May; 113():104523. PubMed ID: 31543246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KRAS mutations drive adenomatoid odontogenic tumor and are independent of clinicopathological features.
    Coura BP; Bernardes VF; de Sousa SF; França JA; Pereira NB; Pontes HAR; Batista AC; da Cruz Perez DE; Albuquerque Junior RLC; de Souza LB; Martins MD; Diniz MG; Gomez RS; Gomes CC
    Mod Pathol; 2019 Jun; 32(6):799-806. PubMed ID: 30643167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenoid 'ameloblastoma': Clinicopathological description of 4 additional BRAF-negative cases.
    Khalaj F; Cinel L; Aminishakib P; Mosavat F; Soluk-Tekkesin M
    J Stomatol Oral Maxillofac Surg; 2023 Dec; 124(6S):101585. PubMed ID: 37543210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic Enigma of Adenoid Ameloblastoma: Literature Review Based Evidence to Consider It as a New Sub Type of Ameloblastoma.
    Jayasooriya PR; Abeyasinghe WAMUL; Liyanage RLPR; Uthpali GN; Tilakaratne WM
    Head Neck Pathol; 2022 Jun; 16(2):344-352. PubMed ID: 34282559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of MAPK/ERK pathway proteins and KRAS mutations in adenomatoid odontogenic tumors.
    Bologna-Molina R; Ogawa I; Mosqueda-Taylor A; Takata T; Sánchez-Romero C; Villarroel-Dorrego M; Takeda Y; Mikami T
    Oral Dis; 2019 Mar; 25(2):481-487. PubMed ID: 30294831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular diagnostics in odontogenic tumors.
    Buettner R; Gültekin SE
    Pathologie (Heidelb); 2022 Aug; 43(Suppl 1):81-85. PubMed ID: 36378285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The molecular basis of odontogenic cysts and tumours.
    Gomes IP; Bastos VC; Guimarães LM; Gomes CC
    J Oral Pathol Med; 2023 Apr; 52(4):351-356. PubMed ID: 36629457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The BRAF p.V600E mutation is a common event in ameloblastomas but is absent in odontogenic keratocysts.
    Zhang R; Yang Q; Qu J; Hong Y; Liu P; Li T
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2020 Mar; 129(3):229-235. PubMed ID: 31987674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenoid Ameloblastoma with Dentinoid: A systematic review.
    Sachdev SS; Chettiankandy TJ; Sardar MA; Adhane Y; Shah AM; Grace AE
    Sultan Qaboos Univ Med J; 2022 Aug; 22(3):325-338. PubMed ID: 36072074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of BRAFV600E and SMOF412E mutations in epithelial odontogenic tumours.
    Diniz MG; Gomes CC; Guimarães BV; Castro WH; Lacerda JC; Cardoso SV; de Faria PR; Dias FL; Eisenberg AL; Loyola AM; Gomez RS
    Tumour Biol; 2015 Jul; 36(7):5649-53. PubMed ID: 25854168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A rare case of peripheral adenoid ameloblastoma with dentinoid.
    Alramadhan SA; Ruddocks LA; Bhattacharyya I; Cohen DM; Islam MN
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2023 Jan; 135(1):e10-e13. PubMed ID: 36396590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic Study of
    Kokubun K; Yamamoto K; Akashi Y; Chujo T; Nakajima K; Matsuzaka K
    Int J Surg Pathol; 2022 Jun; 30(4):378-384. PubMed ID: 34994576
    [No Abstract]   [Full Text] [Related]  

  • 17. The diagnostic utility of BRAF VE1 mutation-specific immunohistochemistry in ameloblastoma.
    Mendez LD; Wolsefer NS; Asa SL; Wasman J; Yoest JM; Stojanov IJ
    Mod Pathol; 2022 Nov; 35(11):1570-1577. PubMed ID: 35676332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenoid ameloblastoma with dentinoid.
    Saxena K; Jose M; Chatra LK; Sequiera J
    J Oral Maxillofac Pathol; 2012 May; 16(2):272-6. PubMed ID: 22923903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The importance of BRAF-V600E mutation to ameloblastoma metabolism.
    Duarte-Andrade FF; Silva AMB; Vitório JG; Canuto GAB; Costa SFS; Diniz MG; Fernandes AP; de Toledo JS; André LC; Gomes CC; Gomez RS; Fonseca FP
    J Oral Pathol Med; 2019 Apr; 48(4):307-314. PubMed ID: 30739334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRAF p.V600E mutations are not unique to ameloblastoma and are shared by other odontogenic tumors with ameloblastic morphology.
    Brunner P; Bihl M; Jundt G; Baumhoer D; Hoeller S
    Oral Oncol; 2015 Oct; 51(10):e77-8. PubMed ID: 26306423
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.